BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal
24 juin 2022 09h00 HE
|
BriaCell Therapeutics Corp.
Anti-Cancer activity of BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer patients was published in a leading peer-reviewed publication. Bria-IMT™, through a novel mechanism of action,...